Literature DB >> 10904403

Comparison of dengue infection in human mononuclear leukocytes with mosquito C6/36 and mammalian Vero cells using flow cytometry to detect virus antigen.

F F Sydow1, M A Santiago, P C Neves-Souza, D I Cerqueira, A S Gouvea, M F Lavatori, A L Bertho, C F Kubelka.   

Abstract

Fluorescent activated cell sorter (FACS) analysis is useful for the detection of cellular surface antigens and intracellular proteins. We used this methodology in order to detect and quantify dengue antigens in highly susceptible cells such as clone C6/36 (Aedes albopictus) and Vero cells (green monkey kidney). Additionally, we analyzed the infection in vitro of human peripheral blood mononuclear leukocytes (PBML). FACS analysis turned out to be a reliable technique to quantify virus growth in traditional cell cultures of C6/36 as well as Vero cells. High rates of infection were achieved with a good statistical correlation between the virus amount used in infection and the percentage of dengue antigen containing cells detected in infected cultures. We also showed that human monocytes (CD14+) are preferred target cells for in vitro dengue infection among PBML. Monocytes were much less susceptible to virus infection than cell lines but they displayed dengue antigens detected by FACS five days after infection. In contrast, lymphocytes showed no differences in their profile for dengue specific immunofluorescence. Without an animal model to reproduce dengue disease, alternative assays have been sought to correlate viral virulence with clinical manifestations and disease severity. Study of in vitro interaction of virus and host cells may highlight this relationship.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10904403     DOI: 10.1590/s0074-02762000000400007

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  7 in total

1.  NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.

Authors:  E L Azeredo; L M De Oliveira-Pinto; S M Zagne; D I S Cerqueira; R M R Nogueira; C F Kubelka
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Detection of infective poliovirus by a simple, rapid, and sensitive flow cytometry method based on fluorescence resonance energy transfer technology.

Authors:  Jason L Cantera; Wilfred Chen; Marylynn V Yates
Journal:  Appl Environ Microbiol       Date:  2009-11-20       Impact factor: 4.792

3.  Flow cytometry-based assay for titrating dengue virus.

Authors:  C R Lambeth; L J White; R E Johnston; A M de Silva
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion.

Authors:  Carey L Medin; Katherine A Fitzgerald; Alan L Rothman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection.

Authors:  Justin B Callaway; Scott A Smith; Karen P McKinnon; Aravinda M de Silva; James E Crowe; Jenny P-Y Ting
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

6.  Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection.

Authors:  Patrícia C F Neves-Souza; Elzinandes L Azeredo; Sonia M O Zagne; Rogério Valls-de-Souza; Sonia R N I Reis; Denise I S Cerqueira; Rita M R Nogueira; Claire F Kubelka
Journal:  BMC Infect Dis       Date:  2005-08-18       Impact factor: 3.090

7.  Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model.

Authors:  Justin B Callaway; Scott A Smith; Douglas G Widman; Karen P McKinnon; Frank Scholle; Gregory D Sempowski; Dirk P Dittmer; James E Crowe; Aravinda M de Silva; Jenny P-Y Ting
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.